Market Introduction
Healthcare contract research organization generally assists biotechnology, medical device, and pharmaceutical companies in the form of research services outsourced on a contract basis. Secured services include preclinical and clinical testing, clinical research, product development such as drug development or process development such as bioanalytical assay development. These organizations also provide management services such as clinical trial management and pharmacovigilance.
Market Overview and Dynamics
The Asia Pacific healthcare contract research organizations (CRO) services market is to reach US$ 16,745.94 million by 2027 from US$ 7,559.03 million in 2019. The market is anticipated to grow at a CAGR of 10.6% during 2019–2027. Factors such as growing number of clinical trials and increasing expenditure in R&D and outsourcing activities are driving the growth of the market. However, dearth of skilled professional is a major factor hindering the market growth.
Key Market Segments
In terms of service type, the clinical research services segment accounted for the largest share of the Asia Pacific healthcare contract research organizations (CRO) services market in 2019. Oncology segment accounted for the largest share of the Asia Pacific healthcare contract research organizations (CRO) services market, by therapeutic indication, in 2019. In terms of end-user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the Asia Pacific Healthcare contract research organizations (CRO) services market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Asia Pacific healthcare contract research organizations (CRO) services market report are the World Health Organization (WHO), the International Society for Pharmaceutical Engineering, the China Food and Drug Administration (CFDA), National Cancer Registry Programme of the India Council of Medical Research (ICMR), India Brand Equity Foundation (IBEF) and others.
Reasons to buy report
ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET SEGMENTATION
By Service Type
By Therapeutic Application
By End-User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 7,559.03 Million |
| Market Size by 2027 | US$ 16,745.94 Million |
| CAGR (2019 - 2027) | 10.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Service Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market is valued at US$ 7,559.03 Million in 2019, it is projected to reach US$ 16,745.94 Million by 2027.
As per our report Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, the market size is valued at US$ 7,559.03 Million in 2019, projecting it to reach US$ 16,745.94 Million by 2027. This translates to a CAGR of approximately 10.6% during the forecast period.
The Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market report:
The Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)